Please provide your email address to receive an email when new articles are posted on . There are few data on the optimal antiplatelet and antithrombotic regimen for patients with mechanical valves ...

Platelets are pivotal contributors to arterial thrombosis. Dual antiplatelet therapy with aspirin and clopidogrel has become the standard of care for the secondary prevention of cardiovascular events ...

Ray and colleagues' retrospective cohort study used automated access to data to evaluate patients who had received clopidogrel during a focused analysis from 1999 to 2005 in a Tennessee Medicaid ...

Please provide your email address to receive an email when new articles are posted on . Clopidogrel has been the primary antiplatelet agent prescribed since its approval by the FDA in November 1997.

Aspirin and other antiplatelet agents are widely used in patients with chronic kidney disease. However, their use is often based on data obtained in patients with normal renal function. A recent ...

Clopidogrel, an antiplatelet agent frequently used for secondary stroke prevention, is a prodrug that requires both sufficient intestinal absorption and hepatic modification to produce its active ...

Because of recently updated recommendations by the American College of Cardiology Foundation and American Heart Association about how to treat patients with cardiovascular disorders with antiplatelet ...

Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...

According to a new study, current evidence suggests that stopping antiplatelet or anticoagulant therapy before simple dental ...

CHICAGO, IL—When added to aspirin therapy, vorapaxar, the first of a new class of investigational antithrombotic agents, reduces the risk of cardiovascular death, myocardial infarction (MI), or stroke ...

“Mechanistic data argue for the use of more potent antiplatelet drugs,” Sibbing said during the presentation. “Intensified antiplatelet treatment, regardless of whether it was prasugrel or ticagrelor, ...